Prohibit, constrain, encourage, or purchase: how should we engage with the private health-care sector?
Authors:
- 1 August 2016
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 388 (10044) , 613-621
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Recent trends in working with the private sector to improve basic healthcare: a review of evidence and interventionsHealth Policy and Planning, 2016
- The regulation of private hospitals in AsiaThe International Journal of Health Planning and Management, 2014
- Innovation in regulation of rapidly changing health marketsGlobalization and Health, 2014
- What explains regulatory failure? Analysing the architecture of health care regulation in two Indian statesHealth Policy and Planning, 2013
- Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and MexicoPLOS ONE, 2013
- Medicine Sellers and Malaria Treatment in Sub-Saharan Africa: What Do They Do and How Can Their Practice Be Improved?The American Journal of Tropical Medicine and Hygiene, 2007
- Regulating health care in low- and middle-income countries: Broadening the policy response in resource constrained environmentsSocial Science & Medicine, 2007
- How do countries regulate the health sector? Evidence from Tanzania and ZimbabweHealth Policy and Planning, 2000
- "Doi moi" and private pharmacies: a case study on dispensing and financial issues in Hanoi, VietnamEuropean Journal of Clinical Pharmacology, 1999
- Pharmaceutical regulation in context: the case of Lao People's Democratic Republic.Health Policy and Planning, 1997